Welcome to our dedicated page for Aquabounty Technologies SEC filings (Ticker: AQB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Want to know how AquaBounty’s land-based salmon really performs? Investors comb through every 10-K and 10-Q for production costs, yield data, and genetic licensing details. This page pulls every disclosure together, so AquaBounty SEC filings explained simply is more than a promise—it’s a shortcut.
Our platform streams each document from EDGAR the minute it posts, then our AI distills the essentials. Use it for:
- AquaBounty quarterly earnings report 10-Q filing side-by-side with prior quarters.
- Real-time alerts on AquaBounty Form 4 insider transactions real-time to spot buying or selling trends.
- AquaBounty 8-K material events explained in plain English within minutes of release.
The AI layer highlights metrics that matter—feed conversion ratios, RAS construction budgets, or new GMO regulations—so you don’t have to wade through 200 pages. Whether you’re looking for an AquaBounty annual report 10-K simplified overview or detailed AquaBounty proxy statement executive compensation, everything is searchable and linked.
Need deeper context? Our dashboards connect AquaBounty insider trading Form 4 transactions with price moves, deliver concise AquaBounty earnings report filing analysis, and answer natural questions like “How does gene-editing affect margins?”—all while understanding AquaBounty SEC documents with AI.
No more manual downloads. Follow AquaBounty executive stock transactions Form 4, cross-reference footnotes, and receive summaries you can read over coffee. Complex aquaculture disclosures become actionable insights the moment they hit EDGAR.
Overview: AquaBounty Technologies, Inc. (AQB) Form 10-Q for the quarter ended June 30, 2025 reports total assets $26,650,968, total liabilities $13,037,043, stockholders' equity $13,613,925 and cash $729,569 as of June 30, 2025. The company recorded a net loss of $3,373,037 for the three months ended June 30, 2025 (six months: $2,971,902); weighted average shares outstanding ~3.87M.
Material items: the company sold its Indiana Farm (July 2024) and its Canadian subsidiary including broodstock farms and Corporate IP (March 2025), recognized $1.2M of continuing-operations impairment in 2025 (prior 2024 impairments ~$101.9M), received $2.008M loan forgiveness, converted $7.386M of accounts payable into a secured Vendor Note, and recorded $8.506M total debt as of June 30, 2025. Management discloses substantial doubt about going concern due to limited liquidity. A Term Note amendment on July 22, 2025 cured prior default.